First-line treatment with Ocrevus (ocrelizumab) preserved walking abilities and hand function in most people with early relapsing-remitting multiple sclerosis (RRMS) over six years, according to data from a Phase 3b clinical trial and its extension study. The findings were presented in a talk by Robert Bermel, MD, of…
Discussion
I had never known anyone personally who had been admitted to a psychiatric hospital. Walking my husband, Rhead, through those doors was one of the strangest moments of my life — not strange in a dramatic way, but strange in the quiet, disorienting way of realizing your life has become…
Discussion
Patient enrollment is complete in a Phase 3 trial testing a new formulation of Briumvi (ublituximab-xiiy), TG Therapeutics‘Â multiple sclerosis (MS) medication for relapsing forms of the disease, that could be injected at home. The new formulation is designed to be given under the skin, or subcutaneously, every…
Discussion
In multiple sclerosis (MS), mindfulness may increase the time a patient spends asleep while in bed, but physical activity appears to have small and inconsistent benefits on sleep. That’s according to a meta-analysis of five published studies that looked at the impact of interventions designed to improve sleep among…
Discussion
I would say that no one grows up telling themselves that they can’t wait to get their first minivan, but that’s probably just my opinion. I will allow for the possibility that some people have thought that exact thing, but I never did. As I imagine is the case for…
Get regular updates to your inbox.
